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ABSTRACT 

Zebrafish (Dania rerio) is an important model organIsm for the studies of 
vertebrate development and gene expression in the field of molecular biology and 
biomedicine. Its embryonic stem cells provide a unique tool linking in vitra and in 
vivo genetic manipulations of animal genomes. 
The aim of the project was to determine the most suitable embryo stage for the 
isolation and culturing of pluripotent cells of zebrafish embryos. Studies were 
carried out to investigate the expression of two pluripotency markers i.e. Oct4 and 
Sa1l4 at certain embryonic stages employing Immunohistochemistry. The protein 
expression studies indicated maximum expression of Oct4 and Sa1l4 at high stage. 
Primary cultures were initiated from zebrafish high stage embryos in basal 
nutrient medium; supplemented with insulin, selenite, epidermal growth factor 
and Foetal Bovine serum. Experiments were conducted for the determination of 
optimum concentrations of FBS. The growing cultures identified the signs of 
differentiation i.e. melanocytes and neurite formation. Basic fibroblast growth 
factor (bFGF) was found to inhibit the differentiation in cultures. The developed 
pluripotency markers were tested on cultured embryonic cells. Results indicated 
that these markers work well for the identification ofphenotype of embryonic cell 
colonies in zebrafish. 
The establishment of pluripotent cell line will enable knock out and knock in 
technologies to be used in this species and have important applications in 
functional genomics research. 
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1 INTRODUCTION 
Zebrafish is an important model organism for the studies of vertebrate 
development and gene function due to its many favourable characteristics. 
However, one disadvantage of this model system is the absence of embryonic 
stem cell lines for the efficient production of gene knock outs (Robles et aI, 2011). 
There is not much reported work on the pluripotency markers of zebrafish. 
However, Robles et al (2011) reported the expression of some candidate 
pluripotency genes of mouse and human in zebrafish blastomeres at oblong stage 
and somatic cells. Employing real time peR the peak expression of Pou, KIf, 
Sa1l4 and Hsp60 was demonstrated at oblong stage when compared to adult 
somatic cells. Similarly relative gene expression results revealed that there is up 
regulation of pouS during embryonic development with a down regulation after 
oblong stage. There have been no studies reported so far on the protein expression 
ofpluripotency markers at different embryonic developmental stages. Robles et al 
(2011) found the Oct4 protein expression at oblong stage embryos employing 
immunocytochemistry but their transient ES cell cultures were negative for Oct4 
protein which is contradictory to the role of Oct4. Two pluripotency markers Oct4 
and Sa1l4 were selected to analyse their protein expression at different blastula 
stages to identify the most suitable stage for the isolation of pluripotent cells. The 
most commonly used zebrafish embryo stage to derive embryonic stem cell 
cultures is oblong stage (Ma et aI, 2001; Fan et aI, 2004). The embryonic 
blastomeres from one cell stage to mid blastula stage of zebrafish embryos are 
considered to be pluripotent or not yet committed to express a particular fate 
(Kimmel and Warga, 1986; Ho, 1992; Ho and Kimmel, 1993; Strehlow and 
Gilbert, 1993). However the established cell lines are blastula derived cell lines 
rather than embryonic stem cell lines (Xing et aI, 2008). A more detailed 
knowledge of pluripotency specific markers is required for the establishment of 
bona fide ES cells. Here, studies were carried out on the expression of human and 
• 
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mouse pluripotency markers Sa1l4 and Oct4 in zebrafish embryo stages using 
differentiated cells and embryonic cell cultures. I I 
1.1 EMBRYONIC STEM CELLS 
Stem cells are undifferentiated cells that have the ability to continuously divide ,I 
and differentiate into diverse specialized cells such as blood cells and muscle cells. 
There are two basic types of stem cells adult stem cells and embryonic stem cells. 
Adult stem cells are the undifferentiated cells present throughout the animal body 
and play an important role in replenishing dying cells and regeneration of .1 
damaged tissues. Embryonic stem cells (ES cells) are pluripotent embryonic cells 
derived from the inner cell mass of the blastocyst (an early stage embryo). Under 
appropriate conditions, ES cells can differentiate into all cell types including germ 
cells. Therefore, ES cells provide a unique tool linking in vitro and in vivo genetic 
manipulations of animal genomes (Hong et aI, 2003). Embryonic stem cells are 
able to give rise after differentiation to derivatives of three germinal layers 
(ectoderm, endoderm, and mesoderm) and to functional gametes. This property of 
cells is referred to as pluripotency. Moreover, since ES cells have unrestricted 
developmental capacity, they represent a promising source for cell transplantation 
:J 
'.I 
J 
I 
; 
J 
I 
therapies to treat various human diseases (Okita and Yamanaka, 2006). 
Mouse embryonic stem cells were successfully derived in early 1980 (Martin, 
1981; Evans and Kaufman, 1981). This led to the development of the gene 
targeting technology used to generate knockout mice, a technique that has quickly 
become a standard approach for investigating and modelling gene function. Ever 
since the production of first mouse ES cell line in 1981, various attempts have 
been made towards the establishment of ES cells in different vertebrate organisms. 
In 1996 successful ES cell production was reported in medaka (Hong et al, 1996) 
and subsequently first successful human embryonic stem cell line production was 
reported in 1998 (Thomson et aI, 1998). 
The essential features of ESCs are derivation from pre-implantation embryos, 
pluripotency, capability for prolonged proliferation and self-renewal, a normal 
euploid karyotype and the expression of distinctive markers (Allegrucci and 
2 
Young, 2007). To date, ESCs has been derived from mouse, rat non-human 
primate and human embryos. ESCs obtained from different species shares many 
characteristics but there are also some differences. 
Although there is an increasing trend towards derivation of ES cells and putative 
ES like cells (Yi et aI, 2010; Hong et aI, 2010) and short term ES cell cultures 
competency of germ line transmission in zebrafish (Ma et aI, 2001) have been 
reported in some species, so far stable ES cell lines production has been limited to 
few organisms (Wang et aI, 2011). One of the main hurdles is the lack of the 
knowledge of suitable pluripotency markers in these species. 
1.1.1 MECHANISM OF PLURIPOTENCY 
The mechanism of pluripotency is regulated by a set of key transcription factors 
and multiple signalling cascades. These regulatory networks play role in 
• 
Imaintenance of pluripotent and undifferentiated form of ES cells. However a 
slight modification in these signals promotes differentiation (Yamanaka et aI, 
2008). There are numerous signalling pathways (Fig 1.1) that play an important I 
role in maintaining pluripotency during embryogenesis. For instance, the Wnt I 
signalling pathway has important functions in embryogenesis and cancer. TGF-B I 
signalling is essential to maintain ES cell pluripotency, and PTEN signalling plays 
Iimportant roles in the maintenance of hematopoietic stem cell self renewal (Yang 
et aI, 2008). I 
t 
I 
3 

growthL1F Wnt BMP4factors 
1 

STAT3 Ras PI3kinase Smad 
1 
~I Akt'y 
c-Myc ~+-------- GSK3i3 
1 
1 
p-catenin 
f 
I 
... 
self renewal 
Fig 1.1: Interaction of different intracellular signalling pathways in mouse 
ESCs. Expression of C-Myc through STAT 3 signal results in the expression 
c-Myc target genes involved in self-renewal. GSK313 inhibits c-Myc AND s­
catenin expression through pbophorylation and proteasome-mediated 
degradation. The suppression of ERK pathway by BMP/SMAD signalling 
and PI3 kinase pathways favours undifferentiated phenotype of ESCs. Wnt 
signalling plays role in self-renewal through GSK3 inhibition and resultantly 
accumulation of B-catenin and c-Myc (Okita and Yamanka, 2006). 
• 
I 
I 
I 
I 
I 
1.1.1.1 LIF/STAT3 signalling 
Mouse embryonic stem cell can be maintained in a self-renewing state for an 
I 
I 
indefinite period in the presence of leukaemia inhibitory factor (LIF). The 
dimerization of cytokine receptors LlF-R and gp l30 results in the initiation of 
LIF signalling in murine ES cells. The downstream signal is transmitted through 
1 
I
I 
gp130. A number of signalling pathways such as STAT3, phosphatidylinositol 3­
kinase (PI3K) and RaslErk pathways are present downstream of gp130. In STAT 
(signal transducers and activator of transcription) 3 pathway, non-receptor 
tyrosine kinases of Janus-associated tyrosine kinases (Jaks) family are activated 
which subsequently phosphorylate LIF-R and gp 130 on tyrosine residues, which 
in tum results in the phosphorylation of STAT3. Phosphorylated STAT3 
4 
dimerizes and translocates to nucleus and target gene activation. In PBK pathway, 
the phosphatidylinositol-3, 4-bisphosphate (PU-3, 4-P2) and phosphatidylinositol­
3, 4, 5-trisphosphate (PIP3) are generated through the phosphorylation of 
phophoinositides on 3-0H position of inositol ring by PBK. These messengers 
than activate serinelthreonine protein kinase Akt, which phosphorylates its target 
molecules, glycogen synthase kinase (GSK)-3 and pro apoptotic BeL2­
antagonist of death (BAD) protein. In the Ras/Erk pathway, the activation of the 
Rafl MEKI Erk kinase cascade by Ras results in the phosphorylation of Erk target 
molecules, like Elk-I, pro apoptotic protein capase-9, and p90 ribosomal S6 
protein kinase (RSK). Both LIF/STAT 3 and PI3K pathway activation and 
suppression of Ras/Erk signalling stimulates self- renewal in embryonic stem cells. 
1.1.1.2 Wnt signalling 
Wnt signalling and Wnt proteins are thought to play numerous roles during 
development and have been associated with role in stem cell maintenance. It is 
believed that Wnt proteins transmit their signals to i3-catenin through binding to 
cell surface receptors of Frizzled and LRP families. After the signal transmission, 
8-catenins forms a complex with TeF in nucleus and activate transcription ofWnt 
target genes. Wnt signals control the transcription of number of ligands and 
receptors which express during tissue growth to maintain a balance between 
proliferation and differentiation. Sato et al (2004) showed that the activation of 
wnt pathway by 6-bromoindirubin-3'-oxime (BIO), an inhibitor of Glycogen 
synthase kinase-3 (GSK-3), and its function is to stimulate the proteasome 
degradation of cytoplasmic I:.-catenin, helps in the maintenance of both mouse and 
human embryonic stem cells. There was a normal expression of pluripotent state 
specific transcription factors Oct-314, Rex-I and Nanog. For the stem cell 
maintenance it is necessary that the level of several transcription factors including 
the aforementioned be maintained. Pereira et al (2006) showed TeF3, a Wnt 
controlled transcription factor, plays role in controlling the expression of Nanog 
gene in ESCs. Furthermore the activation of i3 -catenin by inhibiting the 
expression of adenomatous polyposis coli gene (APe) resulted in the non­
differentiative potential of mouse embryonic stem cell (Kielman et aI, 2002). 
5 
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1.1.1.3 The TGF ~ signalling pathway 
The TGF ~ superfamily of ligands consists of approximately 40 proteins. These 
proteins transduce signals mainly through two branches. One is SMAD 1/5/8 
which plays role in signal transduction of BMPs (Bone morphogenetic proteins) 
and GDFs (growth and differentiation factors) ligands. The other SMAD2/3 
branch involves signal transduction ofTGF ~ IActivinINodal. Both branches work 
in association with SMAD 4. The two inhibitory SMADs are: SMAD6 for 
SMADl/5 inhibition and SMAD 7 for TGF ~ signalling. The SMADs after 
activation by phosphorylation translocate into the nucleus and regulate gene 
expression in combination with other transcription factors (ShiandJohn, 2003). 
James et al (2005) showed the crucial role of TOF signalling in maintenance of 
human embryonic stem cells. Wnt signalling was found to be involved in SMAD 
2/3 activation. Recently a number of studies have shown the prominent role 
played by TGF signalling in maintenance of hESCs. For example Besser (2004) 
showed that there were high levels of Nodal, LEFTYl and LEFTY2 which are 
controlled by TGF signalling in undifferentiaited hESCs. Similarly role of TGF 
signalling has been found in the maintenance of hESCs in feeder free conditions 
(Amit et aI, 2004). Furthermore Ying et al (2003) identified that BMP4 is the 
growth factor which acts in concert with LIF to maintain undifferentiated 
phenotype of embryonic stem cells in feeder free conditions. 
1.1.2 INTRINSIC DETERMINANATS 
1.1.2.1 OCT4 
Oct4 (Octamer-binding transcription factor 4) also known as oct3 (encoded by 
pouSfl) is a novel member of POU (Pit-Oct-Unc) family of transcription factors. 
A distinctive characteristic of POU family is the presence of POD domain. It is 
comprised of two subdomains one is POD specific (PODs) and the other is POD 
homeodomain (PODHD), connected through a flexible linker. The binding of POD 
factors to an octameric consensus sequence motif of an AGTCAAA T results in 
activation of POU target genes. 
6 
Oct3/4 was first identified in murine embryonal carcinoma cells and its expression 
was found to be strictly limited to pluripotent and totipotent cells (Okamoto et aI, 
1990; Scholer et aI, 1990). The 1.5kb mRNA was found to encode a protein of 
377 amino acids and its expression was rapidly down regulated by Retinoic acid 
(RA) (Okamoto et aI, 1990; Scholer et aI, 1990). Oct4 was found to be expressed 
in oocytes, early cleavage stage embryos and the blastocysts of reM in 
mammalian embryos (Palmieri et aI, 1994) suggesting its vital role in cell 
pluripotency. 
Oct3/4 has been found to play crucial role in mouse embryo development. It was 
revealed through targeted gene deletion that deficient embryos failed to develop, 
as the prospective IeM founder cells differentiate into trophectodermal cells 
(Nichols et aI, 1998). A quantitative study carried out by Niwa et al (2000) 
revealed that a normal expression of Oct4 is necessary for ES cell pluripotency, 
as an over expression of Oct4 results in the derivation of ES cells to primitive 
endoderm or mesoderm, while low level of Oct4 triggers dedifferentiation into 
trophectodennal cells. 
1.1.2.1.1 OCT3/4 TARGET GENES 
Oct4 as a transcription factor target genes encoding FGF 4 whose expression is 
restricted to undifferentiated embryonic stem cells and embryonic carcinoma (Ee) 
cell lines in tissue culturing. It is found to be expressed in IeM of bIastocysts and 
later in distinct embryonic tissues (Yuan et aI, 1995). Similarly a transcription 
factor UTFI (undifferentiated embryonic cell transcription factor 1) expressed in 
pluripotent embryonic stem cells (Okuda et al, 1998) is also transcriptionally 
regulated by Oct3/4 (Nishimoto et aI, 1999). Likewise an acidic zinc finger 
protein encoded by Rex-l (Zfp-42) found abundantly in embryonic stem cells is 
controlled by oct3/4 activity in Rex-1 promoter (Ben-Shushan et aI, 1998) and 
PDGFaR is also one of the few identified oct3/4 target genes regulated by binding 
of Oct4 to the promoter of PDGFaR gene (Kraft et al, 1996). Botquin et al (1998) 
showed by the immunoprecipitation of the first intron of osteopontin (Opn) from 
cavalenty tixed chromatin of Ee sells by Oct3/4 specific antibodies that Opn is 
7 
regulated by Oct3/4. Otx-2, Lefty-I, uri dine phosphorylase (Upp) and Tera genes 
expression depend on oct3/4 (Niwa et aI, 2000). 
Takeda et al (1994) reported the cloning and expression of pou2 in zebrafish. 
Based on amino acid sequence comparison of POD domains, pou2 was found 
most closely related to Oct3. In situ hybridization results showed that pou2 
transcripts are present from 1 cell stage to gastrula stage. The expression is down­
regulated after gastrulation is completed. It was suggested that POU2 acts two 
times in embryo development. First POU2 acts during early proliferation and 
morphogenesis of blastomeres the second time it is involved in neuroectoderm 
development. Burgess et al (2002) suggested that based on chromosomal synteny, 
phylogenetic sequence comparison and expression and functional data, pou2 is the 
zebrafish ortholog of mouse Oct3/0ct4 and human POU5Fl. Pou2 is closely 
related to Oct3/0ct4, 79% similarity in POU-specific domain, 74% in POU­
homeo domain and 38% in linker region (Takeda et al, 1994). Based on 
overexpression of truncated t-pou2 by Takeda et al (1994) and morpholino 
experiments carried out by Burgess et al (2002) it was suggested that pou2 plays 
its role in maintaining undifferentiated and dividing state of cells and its inhibition 
resulted in arrest of embryos at gastrula stage. This is very similar to Oct4 role in 
maintenance of rCM cells in pluripotent state (Scholer et al, 1989; Okazawa et al, 
1991; Nichols et aI, 1998). In zebrafish embryos the precursor cells of enveloping 
layer loose pou2 expression during differentiation in early cleavage stages 
(Hauptmann and Gerster, 1995). Likewise in mouse Oct4 expression is restricted 
to rCM in developing blastocysts and extra embryonic tissues are deprived of 
Oct4 (Nichols et aI, 1998). Oct4 expression was found in murine neural plate and 
the injection of murine Oct4 mRNA into spg mutants resulted in the restoration of 
spg mutant phenotype (Reim and Brand, 2002). However Oct4 alone is not 
sufficient to maintain pluripotency, as LIF withdrawal resulted mouse ES cell 
differentiation. This suggests that there must be additional factors involved in 
pluripotency mechanism. 
1.1.2.2 NANOG 
8 
Another gene identified to playa crucial role in determining the pluripotent stat of 
ICM and preventing differentiation of epiblast is Nanog which is a member of 
Homeodomain proteins (Chambers et al, 2003). Homeodomain proteins are 
involved in early embryogenesis such as Otx2 and Mixl 1 (Hart et aI, 2003). The 
homeodomain of Nanog shares 50% amino acid similarity with NK2 family of 
homeopproteins. Nanog is considered to be a unique divergent homeodomain 
protein. Chambers et aI, (2003) and Mitsui et al (2003), through employing 
different screening strategies, reported the same transcription factor named as 
Nanog capable of maintaining ES cells pluripotency independent of LIF/STAT 
signaling. During mouse embryo development Nanog mRNA is first spotted in 
interior cells of morula than limited to ICM of blastocyst. It is further restricted to 
epiblast in late blastocyst. After that it is down regulated and detectable amounts 
are present in germ cells of genital ridges. In vitro, Nanog is found to be 
expressed in all pluripotent ES (murine and human), EG and EC cell lines 
(Chambers et aI, 2003). Nanog expression was found to be down regulated upon 
differentiation of ESCs. Nanog maintains pluripotency by inhibiting 
differentiation to extraembryonic endoderm (Mitsui et aI, 2003). High levels of 
Nanog enabled human ESCs to grow in feeder free conditions (Darr et aI, 2006) 
and excluded the dependence of mouse ES cells on extrinsic LIF factor (Mitsui et 
aI, 2003). It suggests that Nanog role is conserved in mouse and humans (Pan and 
Thomson, 2007). 
Suzuki et al (2006) revealed that T (encodes earlier marker of mesoderm 
differentiation) and STAT3 bind to a site in Nanog 5' promoter region which 
suggests that Nanog is a downstream effector ofa LIF/STAT3 pathway but more 
investigation is required in understanding the link between Nanog and LIF­
STAT3 signaling. 
Bone morphogenetic proteins (BMPs) signaling is involved in mesoderm 
induction during mouse embryonic development and has also been found to playa 
role in pluripotency maintenance in presence of LIF in ESCs. BMP4 induces Id 
(inhibitor of differentiation) expression through Smad 1 signaling in ESCs. Suzuki 
et a1 (2006) proposed that initially BMPs promote mesoderm differentiation which 
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results in up regulation of T (Brachyury). Both T and activated ST AT3 bind to 
Nanog promoter and stimulate its high expression. Elevated levels of Nanog than 
physically interacts with Smad 1 and blocks the mesoderm progression and 
maintains undifferentiated phenotype ofESCs. 
Nanog 5' promoter region contains a composite element, found to be binding site 
of Oct4 and Sox2. Oct4/Sox2 binding to this element resulted in regulation of 
Nanog transcription and this element is fully conserved among Eutherian 
mammals. Rodda et al (2005) demonstrated binding of Oct4/Sox2 binding to 
Nanog promoter in vitro and in vivo through electrophoretic mobility shift and 
Chip assays and is indeed involved in activity of Nanog in pluripotent cells 
(Kuroda et aI, 2005). In situ hybridization showed that Nanog mRNA is 
detectable in Oct4 deficient embryos (Chambers et aI, 2003), suggesting other 
transcription factors in addition to Oct4 are involved in Nanog regulation. Pan et 
aI, (2006) identified FOXD3 as an activator of Nanog. Oct4-Nanog-FoxD3 was 
found to form a negative feedback loop for maintenance of stem cells self­
renewal and pluripotency (Fig 1.2). Likewise during embryonic development 
Nanog needs to be down-regulated. During ES cell differentiation the down 
regulation of Nanog levels was found to be related to high transcriptional activity 
ofp53 (Lin et aI, 2004). 
Schuff et al (2011) identified Nanog ortholog in zebrafish and this was found 
essential for zebrafish embryo development as its deficiency led to gastrulation 
defects and lethality. They found that mouse Nanog overexpression resulted in 
overcoming of these defects. In the same way zebrafish Nanog played same role 
as of mouse Nanog of proliferation and pluripotency in mouse embryonic stem 
cells (Schuff et aI, 2011). 
1.1.2.3 SOX2 
Sox2 belongs to SOXB 1 subgroup of sox gene family. Sox gene family encodes 
transcription factors with one HMO (high mobility group) DNA binding domain. 
Based on homology within and outside HMO box, Sox 1 and Sox3 are members of 
SOXB 1 group. Sox2 RNA was first identified in morula cells, then in IeM and 
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epiblast, extra embryonic ectoderm and later in germ cells. Sox2 expression is 
also associated with developing CNS (A vilion et ai, 2003). In vitro Sox2 in 
combination with OCT3 /4 stimulate oct-sox enhancer activity. Masui et al (2007) 
showed that Sox2 is optional for this activity and forced expression of Oct4 in 
Sox2 null mouse ES cells resulted in restoration of pluripotency. This indicates 
that Sox2 plays its role in pluripotency through stabilizing the levels of Oct4 in ES 
cells. Fong et al (2008) revealed role of Sox2 in human embryonic stem cell 
pluripotency and self-renewal. Using RNA interference they demonstrated that 
knockdown of Sox2 resulted in increase of trophectodermal markers expression 
(CD9, Cdx2, Ge Ml, hCG, HLA-G, hPL, CK7, and SSEA1) and decrease in stem 
cell markers including Oct4 and Nanog. Furthermore down-regulation of Sox2 
resulted in decreased levels of Oct4 and Nanog to 14% and 17%. This further 
confirms that Sox2 plays a critical role in pluripotency network (Boyer et ai, 2005; 
Rodda et ai, 2005). 
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Fig 1.2: Regulatory network of key transcription factors in maintaining ES 
cell pluripotency and self-renewal. Regulators such as Oct4, Nanog, Sox2 and 
FoxD3 bind to each other's promoter and support or limit each other's 
expression, forming an interconnected auto regulatory network to maintain 
ES cell pluripotency and self-renewal. Arrows connected to factors by solid 
lines indicate positive regulation of a promoter by the factors. Broken lines 
linking to Oct4 indicate negative regulation (Pan and Thomson, 2007). 
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1.1.2.4 SALL4 
The SALL gene family consists of four genes Salll, SaU2, Sall3 and Sall4. It was 
originally cloned based on a DNA sequence homology to the Drosophilla gene 
SaIl. Sall gene family plays an important role in development. In humans mutation 
in salll results in Townes-Brockes syndrome in patients indicating renal, limb, 
anal and ear malfonnations (Kohlase et aI, 1998; Powell and Michaelis, 1999). In 
mice sall 1 null mutant die perinatally because of severe kidney dysgenesis or 
agenesis (Nishinakamura et aI, 2001). No human congenital malformation has 
been associated with Sall2 so far. It is proposed that Sal13 which maps to 
chromosome 18q23 is involved in the phenotype of patients with 18q deletion 
syndrome, which shows the symptoms of developmental delay, hypotonia, growth 
retardation, mid face hypoplasia, hearing loss and tapered fingers. Sal13 null mice 
exhibit plate deficiency, abnormalities in cranial nerves, and perinatal lethality. In 
human Sa1l4 is found to be mutated in patients with Duane Radial Ray syndrome 
(Al-Baradie et aI, 2002) and a range of overlapping phenotypes includes Holt­
Oram, Acro-renal-ocular syndrome, and IVle syndrome (Kohlhase et aI, 2003; 
Paradisi and Arias, 2007). 
In addition to the role in development Sall gene family has found to play an 
important role in human and murine embryonic stem cells and in early embryonic 
developments. Sa1l4 (Sal-like protein 4) has been found to express at 2 cell stage 
similar to Oct4. 
In humans there are two Sa1l4 isofonns Sa1l4A and Sa1l4B. Yang et al (2010) 
reported that both Sa1l4 isoforms trigger the Oct4 expression but suppress those of 
Salll and Sal13. In turn Oct4 was found to activate the expression of Sal14, Salll 
and Sal13, which suggests that a positive transcriptional feedback loop exists 
between Sall gene family members and Oct4. Both Sall4 isoform can inhibit its 
own promoter in a dose dependent manner and Sa1l4 activation by Oct4 is 
determined by Sa1l4 expression level. Conclusively Sa1l4 expression is strongly 
regulated by self-repression and a positive feedback from Oct4. 
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In murine ES cells, Sa1l4 has been found to play a fundamental role in 
maintaining pluripotency and through transcriptional regulation of Oct4 and 
Nanog governs the decisions involving the fate of ES cells. Sa1l4/0 ct4INanog 
transcriptional core network is crucial for the maintenance of 'sternness' of ES 
cells and Sa1l4 has been shown to trigger Oct4 and interact with Nanog (Yang et 
aI, 2010). Fig 1.3 shows the no. of genes co-occupied by these proteins. It shows a 
total number of 48 genes are co-occupied by Oct4, Sa1l4 and Nanog. Under 
appropriate culture conditions reduction in Sa1l4 levels in mouse ES cells results 
in re specification of ES cells to trophoblast lineage. Sa1l4 regulates transcription 
of pouSfl which encodes Oct4, by binding to the highly conserved regulatory 
region of pouSfl distal enhancer and triggers pouSfl expression in vivo and in 
vitro . Hence it shows that Sa1l4 by regulating Oct4 expression plays an essential 
role in maintenance of ES cell pIuri potency. It also plays an important role for 
early embryonic cell fate decisions (Zhang et ai, 2006). 
Sal14 

3,223 genes 

92 Genes 
48 Genes 
Oct4 
783 genes 
Fig 1.3: Venn diagram showing the overlapping target genes of SaJl4, Oct4, 
and Nanog as determined by ChIP-Chip and ChIP-PET experiments. These 
complexes may function in the regulation of stem cell pluripotency (Yang et 
al,2008). 
1.2 APPLICATIONS OF EMBRYONIC STEM CELL CULTURES 
The remarkable characteristic of pIuri potency of embryonic stem cells has many 
important applications. The generation of mouse ES cell lines has enabled the 
investigation of gene function through gene targeting technology (Capecchi, 
1989). ES cell s can contribute to gem1 cell lineage after transplantation into host 
embryos so they can be utilized as vectors for production of transgenic animals. 
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This is advantageous over conventional trans genesis methods, as the cells can be 
manipulated in vitro and colonies can be selected on the basis of their desirable 
transgene expression (Collodi, 1996). In vivo analysis of roles of individual genes 
during embryo development and growth was made possible due to mouse knock 
out production (Nasevicius and Ekker, 2000). The directed dedifferentiation of 
ESCs to specific cell types such as cardiomycetes or neurons will both serve as a 
source of drug discovery and transplantation therapies for Parkinson disease, 
neurodegenerative diseases and myocardial infarction etc (Thomson et aI, 1998). 
The availability of ES cell system will enable manipulation of ESCs to quantify 
the effect of drugs. They have already been used in studying the role of specific 
genes, in identification of progenitors involved in hematopoietic, vascular, and 
neural development (Keller, 2005). 
Although the properties of embryonic stem cells make them a promising source in 
cell replacement therapies there are still a number of obstacles which are keeping 
them away from their clinical applications e.g. their pluripotency results in the 
formation of haphazard cells leading to teratomas and teratocarcinoma formation 
in vivo (Wu et aI, 2007). 
1.3 ZEBRAFISH AS A MODEL ORGANISM 
Zebrafish was first used as a model by Dr Georges streisinger, a scientist working 
in developmental genetics at the University of Oregon, Washington, USA 
(Westerfield, 1993). Zebrafish, Danio rerio, a tropical fresh water fish belong to 
Cyprynidae family and it is native to Pakistan and India. Among teleosts, the 
zebrafish is an important experimental animal in developmental biology, 
physiology, genetics, and biomedical research (Buono and Linser, 1992; Squire et 
aI, 2008). Zebrafish exhibit many features that make them an ideal genetic model 
organism as they are easy to maintain and manipulate in the laboratory. Zebrafish 
has a relatively short generation time of 3-4 months and produces a large number 
of embryos throughout the year making it feasible for large scale genetic 
screening. The optically transparent embryo develops ex vivo making them well­
situated for a wide range of experimental manipulations (Gerhard, 2003). As 
zebrafish is a vertebrate organism, it shares a high genomic, proteomic and 
14 
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metabolomic homology with other vertebrates and was termed as "canonical 
vertebrate" for its high similarity with mammalian biology. Studies have been 
carried out demonstrating that zebrafish genome can be used for the analysis of 
genes homologs of humans (Rubinstein, 2003). The work carried out by 
Karlovich on Huntington disease gene homolog in zebrafish (Karlovich et aI, 
1998), similarly cloning of zebrafish homologs of human enzymes involved in 
steroidogenesis (Lai et aI, 1998) and cloning of zebrafish gene involved in 
Alzheimer's disease (Leimer et aI, 1999), supports the use of zebrafish as model 
of human diseases studies. The studies on zebrafish heart, vasculature, blood and i 
"I 
kidney development were found to be significantly relevant to medicinal studies 
(Ackerman and Paw, 2003). 
1.3.1 NEED FOR ZEBRAFISH EMBRYONIC STEM CELLS 
In the last two decades remarkable progress has been achieved with culture of 
murine and human embryonic stem cell lines. However there is very limited 
!f 
report in the literature on fish stem cell culture (Xing et al, 2008). The production 
of mouse knock outs using pluripotent ES cell cultures has served as a valuable 
tool in study of gene function during embryogenesis and growth (Ekker et aI, 
2001; Weinholds et aI, 2002), but cell mediated gene transfer has not been 
achieved in this specie. The main reason for this is the non-availability of 
zebrafish ES cell lines that remain germ line competent for multiple passages 
(Wong et aI, 2006). 
There is a continuous effort being made to establish zebrafish embryonic stem cell 
lines and reports have been published on the derivation of pluripotent ES cells, e.g. 
there are reports demonstrating the germ line competency of zebrafish cell 
cultures (Fan et aI, 2004) and homologous recombination in these cultures (Fan et 
aI, 2006). However, despite these great advances, only zebrafish blastula cell lines 
have been established (Xing et aI, 2008). 
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1.3.1 DEVELOPMENTAL STAGES OF ZEBRAFISH EMBRYOS 

Zebrafish development is show in Fig 1.4. The main key events taking place 
during development are: 
Zygote Period: the newly fertilized egg enters zygote period after first cleavage, 
which takes place app. 40 minutes after fertilization. During this period, 
cytoplasm streams toward animal pole to form blastodisc. 
Cleavage period: this period lasts for around 2 hours and consists of2-cell stage to 
64-cell stage. During this phase 6 cleavages occur and cells or blastomeres divide 
synchronously at 15 minute interval. The cytoplasmic divisions are meroblastic 
that means that blastomeres remain connected through cytoplasmic bridges. 
Blastula period: this period covers 128-cell stage to 30% epiboly stage and lasts 
from 2h 15m - 5h 15m. During this period, blastodisc appears like a ball shape. 
The main events are; embryo enters (mid blastula transition) MBT at 10th cleavage 
i.e. is 512-cell stage, the embryo is formed of three layers: the enveloping layer 
(EVL), deep cells and the yolk syncytial layer (YSL), and epiboly begins, 
characterized by spreading of YSL and blastodisc over the yolk cells, and reaches 
30% of distance between the animal and vegetal poles. 
Gastrula period: this period ranges from 5h 20m - 10h and covers 50% epiboly to 
bud stage. During this phase epiboly continues and cell movements of involution, 
convergence and extension results in the formation of primary germ layers i.e. 
epiblast (later gives rise to endoderm) and hypoblast (that will form a mixture of 
ectoderm and mesoderm) and the embryonic axis. 
Segmentation period: it lasts for 10h -24 h and covers 3-26 somite stage. Somites, 
pharyngeal arch primordia, and neuromeres develop; primary organogenesis and 
appearance of tail are marked features during this period. 
Pharyngula Period: this period covers Prim-6- High pec stage and lasts up to 24h 
to 48h. The body axis straightens from its early curvature about the yolk sac; 
circulation, pigmentation and fin development begins. 
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Hatching period: it is the last period and comprises of Long pec- protruding 
mouth and continues from 48h-72h. This phase is marked by morphogenesis of 
primary organ systems, cartilage development in head 
hatching occurs asynchronously (Kimmel et aI, 1995). 
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A: 2- cell stage B: 4-cell stage c: 8-cell stage 0: 16-cell E: 32-cell stage f: 64-cellstage 
stage 
Fo E 
A: 256 cells B: High stage c: Oblong 0: Sphere E: Dome stage f: 30% 
stage Epiboly stage 	 stage 
c 
'" 
A:50% epiboly B: Cerm ring s 	 C: Cerm ring 0: Shield E: Animal pole F: 70% 
(Animal pole view epiboly 
view) 
G:70% epiboly H: 75% epiboly I: 80% epiboly 	 J: 90% K: 90% L: Bud stage 
epiboly stage epibolystage stage 	 stage 
Fig 1.4: Embryonic Development stages of zebrafish (Cleavage, Blastula and 
Gastrula Period) (Kimmel et ai, 1995). 
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1.4 CELL CULTURING 

Cell or tissue culturing, the cultivation and growth of cells in vitro, has become an 
important tool in biomedical sciences. There is an increased use of in vitro cell 
culturing in basic cell and molecular biology research and other disciplines such 
as pharmacology, toxicology and physiology. There is a need of appropriate 
culture environment that represents the physiological condition of cells in vivo, for 
successful growth and propagation of cells (Davis, 2002; Masters, 2000). The 
micro-environment of cells is made up of three components (Fig 1.5); the culture 
substratum i.e. is the culture dish or specifically coated surfaces for cell 
attachment, the culture medium consisting of all types of nutrients and cell to cell 
interaction (Gastraunthaler, 2003). 
··1 
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Fig 1.5: Parts of the microenvironment of the cell in vivo and in vitro. (1) the 
diffuse environment, in vitro provided by culture medium, (2) the contact 
environment (cell-matrix attachment), (3) the junctional connections between 
neighbouring cells (cell-cell adhesion) (Gastraunthaler, 2003). 
1.4.1 EMBRYONIC STEM CELL CULTURE 
Embryonic stem cell cultures are derived from the inner cell mass (rCM) of the 
early embryo blastocysts. There are two approaches for obtaining rCM derived 
cells. The first technique involves the transfer of whole preimpiantation 
blastocysts into tissue culture. After hatching, embryos attach to culture dish by 
trophectoderm and subsequently IeM is exposed after trophectoderm spread over 
the culture surface. reM derived cells are allowed to grow for additional few days 
till they are dissociated and replated (Evans and Kaufman, 1981; Robertson, 
1987). The second technique involves the immunosurgical removal of reM from 
;) 
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blastocyst by selective trophectoderm lysis (Solter and Knowles, 1975; Martin, 
1981) ortreatrnent with calcium ionophore A23187 (Surani et ai, 1978). 
The isolated IeM are then transferred to culture dish containing appropriate 
medium in presence of feeder layers and allowed to grow for a few days. The cell 
aggregates are collected before they are getting too large and dissociated in 
trypsinJEDTA and transferred onto a new plate with feeder layer. After 2 days in 
culture colonies are apparent. Pluripotent cell colonies possess homogenous 
appearance while differentiating colonies exhibit fibroblastic, epithelial or 
trophoblast -like morphology. After approximately 7 days colonies exhibiting 
stem cell morphology are collected, dissociated and transferred to fresh feeder 
layers. The cells are grown to confluence (Collodi, 1996). 
These are the methods described for derivations of murine embryonic stem cells 
and with minor modification are used for culturing of stem cells of other species. i 
1.4.2 FOETAL BOVINE SERUM 
Foetal bovine serum (FBS) is derived from bovine foetuses through cardiac 
puncture from pregnant cows during slaughter. It is widely used in cell culture due 
to its high content of growth stimulatory factors and low contents of growth 
inhibitory factors. 
The rich content of growth factors and low levels of gamma-globulin as compared 
to other animal sera (Gastraunthaler, 2003) has made FBS the standard medium 
supplement. There are certain advantages in using FBS in culture medium; FBS is 
a combination of growth factors required for cell growth and maintenance, it is 
also considered as universal growth supplement for a variety of both human and 
animal cells. 
However there are a number of disadvantages associated with its use in cell 
culture. FBS is chemically undefined (Bjare, 1992) and can be a potential source 
of contaminants such as microbial. Also there is a batch to batch variability due to 
variations in the serum compositions (Price and Gregory, 1982). 
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1.4.3 GROWTH FACTORS 
A diverse group of polypeptides that modify cell proliferation are growth factors. 
They differ somewhat from classic hormones as neither their synthesis site nor 
their action site is restricted to defined tissues. Many growth hormones work in 
paracrine fashion and in certain instance they can be autocrine. 
1.4.3.1 EPIDERMAL GROWTH FACTOR 
There is a complex network of growth factors and receptors that cooperate to 
modulate the growth of cells. Epidermal growth factor is a part of this complex 
network. After the release of EGF from cells, it can be either picked up by the 
same cell or by the neighbouring cell resulting in stimulation of their ab ility to 
divide and grow. There are receptors present on the surface of the cell which bind 
to EGF and transmit the signal inside (Fig 1.6) (Goodsell, 2003). 
epldermal growlh faclor 
EGF·b;Ild"'g , 
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Fig 1.6: In an unbound state, EGF receptor folds into an inactive form that 
cannot dimerize. Yellow color indicates cysteine amino acids in EGF binding 
domain. EGF binds in the groove at the top. The purple color in tyrosin 
kinase domain indicates drug (Goodsell, 2003). 
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After binding with EGF, receptor is activated by forming a dimer with other 
receptors. Four related receptors have been discovered: the EGF receptor and 
three variants. These receptors may dimerize with themselves or may form 
heterodimers with other types. A varied no of set of growth factors interacts with 
these receptors. These include for example EGF, transforming growth factor­
alpha (Shawver et aI, 2002). The receptor is made up of a single chain with many 
fuctional parts. It is located in the cell membrane with one portion facing out to 
receive the signal and the other facing in to transmit the message to cell 
machinery (Fig 1.7). The outer portion of the receptor form the EGF binding 
domain, comprised of four articulated parts: two globular parts that holds the EGF 
and two rigid rod shaped linkers. After binding of EGF to this multi-part domain, 
it changes its shape relaesaing one of the long cysteine-rich sections, allowing 
receptor to dimerize with others (Goodsell, 2003). 
~. 1 
The inner portion of the receptor is tyrosine kinase enzyme. The kinases add 

phosphate groups to tyrosine residues on the neighboring chain. The signaling ] 

proteins present inside the cell than bind to these phosphorylated tyrosinases, 
'\ 

inducing the signaling cascade that ultimately initiates DNA synthesis and cellular 

growth (Schlessinger, 2000). 

I 
;1 
! 
I 
~ 
22 i 
j 
I 
I 
-L 
, J '" -;::...? t(' -::-; ~ " 
" • r... .>-"S;' ._ _, . ,
"'.... i-~ ,~ ~-, r.~~: ....~; . ;.' / _.' ,'1(tyros ine kinase y,:,-<~~ , " ' : ~- 'Ii '",,';)"domain , J. ! • " " , t -, 
--.:.r 11 ",) ~ -.7 --::' '';;~.?-~
'. "L:'~"- ~ . t-."o-~ 
~../. - '~~.\.:::1'-...~ T'" ~~~j" ~ - . :.. ~ 

, • ~ I , 

autophosphoryJ ati on ~ ( , 

s ites 
Fig 1.7: EGF binding to its receptor followed by change in recceptor shape 
resulting in receptor dimerization. This brings the kinase domains closer 
allowing addition of phospbate groups to each other, resulting in activation of 
signalling process (Goodsell, 2003). 
1.4.3.2 FIBROBLAST GROWTH FACTOR 
Originally FGF was identified as an activity that stimulates the growth of 3T3 
cells in extracts of pituitary and brain. The activity was found to be due to two 
proteins (Annelin, 1973 : Gospodarowicz, 1974). One of them was aFGF that had 
an acidic pI and eluted [rom heparin sepharose with 1 MNaCI (Maciag et aI , 1984, 
Thomas et ai, 1984), the second was bFGF with a basic pI and eluted from 
heparin sepharose with 1.5M NaC I. bFGF shares 55% sequence homology to 
aFGF (Esch et ai , 1985). 
Fibroblast growth factors comprise a large family of polypeptide growth factors 
consisting of 23 members who are structurally related and transduce signal 
through receptors tyrosine kjnases. During embryonic development FGFs play 
crucial ro le in invertebrates and vertebrates (Bo"ttcher and Niehrs, 2005). In vitro 
FGFs act as mitogen for mesoderm and neuroectoderm- derived cells and in vivo 
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found to play role in angiogenesis (Montesano et ai, 1986). Bouche et ai, (1 987) 
showed that during the transition of cells from Go to G j phase bFGF penetrates the 
cell and start localizing in nucleolus and complemented by pre-rRNA synthesis. It 
is one of the structured events taking place in the cells entering from dormant to 
growing stage (Pardee et aI, 1985) and supports the role of bFGF in cell 
proliferation. 
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Fig 1.8: Domain structure of FGF and FGFR proteins. (A) Structure of a 
generic FGF protein consisting of a signal sequence, and the conserved core 
region consisting of rcceptor- and HSPG-binding site. (B) The main 
structural features of I;'GFRs including Ig domains, acidic box, heparin­
binding domain, CAM-homology domain (CHD), transmembl'ane domain, 
and a split tyrosine kinase domain are illustrated with respective functions. 
CAM, Cell adhesion molecule; ECM, extracellular matrix; PKC, protein 
kinase C (Bottcher and Niehrs, 2005). 
FGFs transduce signals through binding and activation of FGFRs. The receptor is 
composed of single transmembrane protein with extracellular ligand- binding 
region for FGF and intracellular domain harbouring tyrosine kinase activity. The 
receptor dimerization due to binding of FGF activates tyrosine kinase and 
resultantly auto phosphorylation of the intracellular domain. 
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Xu et al (2005) confirmed that bFGF in combination of other gro\\1:h factors 
supports the growth of ESCs in feeder free conditions. Furthermore it was found 
that BMP antagonist Noggin in concert with bFGF plays role in maintaining 
undifferentiated phenotype of hESCs in absence of (MEF) mouse embryonic 
fibroblasts (Wang et aI, 2005; Xu et aI, 2005). In vitro, bFGF reduced the 
expression of neural-specific markers in zebrafish embryonic cells possibly 
indicating that it suppresses early neural cell development (Singh et al, 2001). 
1.5 IMMUNOCYTOCHEMISTRY 
Coons et al in 1941 reported the use of an immunoflourescense technique for the 
detection of cellular antigens in tissue sections; this was the beginning of 
immunohistochemistry (IHC). Basically THC technique encompasses three 
scientific fields: immunology, histology and chemistry. The process involves the 
detection of Antigents (A g) within tissue sections by means of specific antibodies 
CAbs). The antigen-antibody (Ag-Ab) binding is evident by a colour histochemical 
reaction visible by light microscopy or fluorochromes with ultraviolet light. 
Earlier attempts included the use of specific antibodies labelled with fluorophore 
itself and applied to the biological samples for the identification of antigenic sites 
known as direct method. Later more sensitive and versatile indirect method was 
introduced which employed a secondary antibody tagged with a fluorophore J 
'1 (FITC, TRITe and rhodamine) or enzyme to detect the specific antibody attached 
to the antigen of interest. 
Immunofluorescence in combination with confocal microscopy is a powerful 
technique for studying of location of proteins and dynamic processes. It is widely 
employed in cytology and pharmacology fields in disease diagnosis and drug 
development (Ramos-V ara, 2005). It has become a vital tool in research and 
diagnostic laboratories. 
1.6 AIMS OF STUDY 
The objectives of this study were: 
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1. 	 Development of suitable pluripotency markers in zebrafish, by 
analysing the expression of different pluripotency genes employing 
immunocytochemistry. 
2. 	 Identification of most suitable stage for isolation of pluripotent cell of 
zebrafish embryo. 
3. 	 In vitro culturing of zebrafish pluripotent cells in a simplified medium. 
4. 	 Application of pluripotency markers in cultured zebrafish embryonic 
cells. 
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2 METHODSANDMATERIALS 
2.1 GENERAL METHODS 
All experiments were carried out in the laboratories at IBEST institute, University 
of Bedfordshire. There is not much reported work on behaviour of pluripotency 
markers in Zebrafish embryonic cultures (Robles et aI, 2011). This can be one of 
the hurdles towards the successful establishment of Zebrafish ES cell lines. So, 
studies were carried out on the development of pluripotency markers in zebrafish 
species. Experiments were conducted for the analysis of protein expression of 
candidate pluripotency markers i.e. Oct4 and Sa1l4 of mouse and human at 
different Zebrafish embryo stages. These studies led to the identification of 
suitable embryonic stage for derivation of ESCs. Further, the application of these 
pluripotency markers was analyzed on cultured embryonic cells. 
2.1.1 ZEBRAFISH MAINTENANCE 
Adult Zebrafish (Fig 2.1) was provided to IBEST by Aquascope, LTD 
(Birmingham, UK). They were maintained in 30 litres tank (28x 28x58 em) at 
28°C, with tap water which was aged 12- hrs before use. There are temperature 
control and filtration systems in each tank. Males and females were kept together 
with a ratio of 1:2 (25 to 30 fish in each tank). The fish tanks were cleaned weekly 
with and over 80% of the water changed weekly with complete renewal every 4 
weeks. Automatic light cycle control was set for light/dark = 12/12h. 
27 

Fig: 2.1: Adult males and females Zebrafish. Picture adapted from 
(http: //www.cosmosmagazine.com ). 
2.1.2 FEEDING 
Adult fish were fed three times a day wi th Tetra Min flakes fish food produces by 
Tetra, Germany. To enhance their breeding process the fish were also fed once a 
day with live adult brine shrimps. Excess of the food in the water was removed. A 
holiday tablet fish food was put inside the tank at weekends and holiday peliods. 
2.1.3 BREEDING AND EMBRYO COLLECTION 
When female fish reach three months of age and the average length and weight of 
24.9mm and 1100mg respectively, they are ready to start spawning. Each female 
fish spawns between 200 and 600 eggs per event. Zebrafish breed daily shortly 
after dawn, or after light is turned on in captivity. Embryos were collected from a 
glass tray covered by a plastic net. Embryos were then kept in beakers at 28 °C 
water tank until they reach the desired stage. 
2.2 DECHORIONATION AND DEYOLKING OF ZEBRAFISH 
EMBRYOS AND ISOLATION OF BLASTOMERES 
The experiments for cell culturing were carried out using high stage embryos 
(3.3hpf) as previous studies have demonstrated that blastula derived cell lines 
were derived from oblong stage embryos (Xing et aI , 2008). 
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Once the embryos reached the appropriate stage for experiments (Fig 2.2) (high 
stage) for cell culture, and (128-cell stage, high stage, oblong stage, dome stage 
and 50% epiboly) fo r pluripotency markers, dead and unfertilized embryos were 
removed. Viable embryos were placed in a 6 well plate and tap water was 
replaced with embryo medium. Embryos were rinsed several times with water and 
then rinsed with LDF medium (50% Leibowitz' s L-lS, 35% Dulbecco ' s Modified 
Eagle's Medium, and 15% Ham's F12) three times. After LDF removal embryos 
were washed with bleach solution (0.5% in ddH20 ) for no more than 2 minutes. 
Embryos were then immediately rinsed with LDF medium. B leach treatment was 
repeated twice and rinsed two additional times with LDF medium. Embryos were 
dechorionated with incubation in O.Smg/ml pronase solution until the chorions 
start breaking apart. Chorions were also removed mechanically with sharp fo rceps 
and needles. Dechorionated embryos were placed in embryo medium. Embryos 
were deyoked with needles and yolk gets dissolved in embryo medium. Separated 
blastomeres were than washed in LDF medium. Blastomeres were then 
transfened to I.Sml eppendorf tube. Blastomeres were dissociated with gentle 
pipetting. Cells were collected by centrifugation at 1500g for Sminutes. Number 
of embryos used per treatment was around 10. 
D t: 
Fig 2.2: Zebrafish embryo development stages for analysis of Oct4 and SaU4 
protein expression. A: Early Blastula stage, B: High stage, C: Oblong stage, 
D: Dome stage, E: 50% epiboly (Kimmel et ai, 1995). 
29 
2.3 DEVELOPMENT OF PLURIPOTENCY MARKERS 

One of the factors required for the successful establishment of zebrafish ES cell 
lines, is the detailed analysis of pluripotency genes in this specie. There is not 
much reported work on the pluripotency markers available in this specie (Robles 
et aI, 2011). The aim of these experiments was to analyse the expression of human 
and mouse pluripotency genes i. e. Oct4 and Sall4 in different zebrafish embryo 
stages. Robles et al (2011) reported a peak expression of Pou and Sall4 at oblong 
stage embryos as compared to somatic cells. We aim here to analyze the protein 
expression employing immunocytochemistry. 
Commercially there are no antibodies against these antigens are present 
specifically for zebrafish specie. For this purpose bioinformatic analysis was done 
to identify the homology in the antibody binding site in both species. 
2.3.1 BIOINFORMATIC ANALYSIS .i 
The protein sequences of Oct4 and Sa1l4 in zebrafish were obtained from NCB I 
(http://www.ncbi.nlm.nih.gov/) (Table 2.1). The sequences were run against 
human and mouse sequences for Oct4 and Sa1l4 respectively in ClustalW 
(http://www.ebi.ac.uklTools/msalclustalw2/) to identify the homology in antibody 
binding site (Fig 2.3 and 2.4). As the primary antibodies used in the experiments 
for the analysis of protein expression in zebrafish embryo stages, were specific for 
human (Oct4) and mouse (Sall4) species. 
J 
) 
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Table 2.1: Table shows gene name, gene ID and accession no. of mRNA and 

protein sequence for mouse, human and zebrafish. 

Gene Specie GeneID Ref Seq (mRNA) 	 Ref 
Seq (Protein) 
1 
Mus 18999 NM 013633.1 NP 038661.1 

musculus 

Oct4 Homo sae.iens 5460 NM 002701.3 NP 002692.2 

Danio rerio 303333 NM 131112 NP 571187 
Mus 99377 NM 175303.3 NP 780512.2 
musculus 
Homo saeiens 57167 NM 020436.3 NP 065169.1 Sa1l4 
1 
Danio rerio 572527 NM 001080609.1 NP 001074078.1 
)
.. 
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giI18859249I ref INP_571187.11 
giI400659ispIQ01860.1IP05F1_HU 
giI18859249IrefINP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
giI188592 49 Ire fINP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
giI18859249I ref INP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
giI18859249I ref INP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
giI18859249IrefINP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
giI188592 49 Iref INP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
giI18859249IrefINP_571187.11 
giI400659IspIQ01860.1Ip05Fl_HU 
giI18859249IrefINP_571187.11 
giI400659IspIQ01860.1I P05Fl_HU 
giI18859249IrefINP_571187.11 
giI400659IspIQ01860.1IP05Fl_HU 
Fig 2.3: Sequence alignment 
-

MTERAQSPTMDCRPYEVNRAMYPQAAGLDGLGGASLQFAHGJvIT..QDPSLI 50 
MAGHLASDFAFSP----------PPGGGGDGPGGP----------EP--- 27 
*. . * * * * ** ** . * 
FNKAHFNGITPATAQTFFPFSGDFKTNDLQGGDFTQPKHWYPFAF.PEFTG 100 
--------------------------------GWVDPRTWLSFQGPPGG- 44 
.. *. * * * 
QVAGATAATQPANISPPIGETREQIKMPSEVKTEKDVEEYGNEENKPPSQ 150 
-----------PGIGPGVGPGSEVWGIP---PCPPPYEFCGG~.yCGP-- 78 
**"* * '* * * * 
YHLTAGTSSVPTGVNYYTPWNPNFWPGLSQITAQANISQAPPTPSASSPS 200 
---QVGVGLVPQGG--LETSQP---EGEAGVGVESNSDGASPEPCTVTP- 119 
* ** * .* * .... * *** ..* 
LSPSPPGNGFGSPGFFSGGTAQNIPSAQAQSAPRSSGSSSGGCSDSEEEE 250 
-----------------G--AVKLEKEKLEQNPEES-----------QDI 139 
* *..
.. . . 
..
.. 
* 
.. 
* .. 
TLTTEDLEQF~~ELKHKRITLGFTQADVGLALGNLYGKMFSQTTICRFEA 300 
KALQKELEQFAKLLKQKRITLGYTQADVGLTLGVLFGKVFSQTTICRFEA 189 
.. ****** **.******.*******.** *.**.*********** 
LQLSFKNMCKLKPLLQRWLNEAENSEN?QDMYKIERVFVDTRKRKRRTSL 350 
LQLSFKNMCKLRPLLQKWVEEADNNENLQEICKAE-TLVQARKRKR-TSI 237 
***********.****.* .. **.* ** * .. * * .* .. ***** **.I ••••• •• • 
EGTVRSALESYFVKCPKPNTLEITHISDDLGLERDVVRVWFCNRRQKGKR 400 
ENRVRGNLENLFLQCPKPTLQQISHIAQQLGLEKDVVRVWFCNRRQKGKR 287 
** .*.** ... ****.***************** ** *.. **** .  .., 
L~LPFDD-ECVEAQ--YYEQSPPPPPHMGGTVLPGQGYPGPAHPGGAPAL 447 
SSSDYAQREDFEA.n.GSPFSGGPVSFPLAPGPHFGTPGYGSPHFTALYSSV 337 
. ., * ** . ;, * * . ** * .. 
• " I '" 
YMPSLHRPDVFKNGLHPGLVGHLTS- 472 

PFP---EGEAFPPVSVTTLGSPMHSN 360 

.* 
. * * . * 

of zebrafish POU against human POU5f1 
(http://www.ncbi.nlm.nih.govD. Antigenic peptide was raised from within 
residues 300 to the C-terminus of human Pou5f1 
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gl1321727751gb1AAH53716.11 
gil 123705627IEefINP_001074078. 
gi1321727751gblAAH53716.11 
giI123705627I EefINP_001074078. 
gi1321727751gb1AAH53716.11 
giI123705627IEefINP_001074078. 
gl1321727751gblAAH53716.11 
gil1237056271EefiNP 001074078. 
gi1321727751gb1AAH53716.11 
gil1237056271EefiNP 001074078. 
gil32172775 19b lAAH53716.11 
gil1237056271EefiNP 001074078. 
gi1321727751gb1AAH53716.11 
giI123705627IrefINP_001074078. 
gi1321727751gb1AAH53716.11 
giI123705627IEefINP_00I074078. 
gi1321727751gb1AAH53716.11 
giI123705627IrefINP_001074078. 
-

MSRRKQAKPQHINWGEGQGEQPQQLPSPDLAEALAAEEPGAPVNSPGNCD 50 

MSRRKQSRPQHINSDDP-----------------ASTENGILHNS----- 28 

EASEDSIPVKRPRREDTHICNKCCAEFFSLSEFMEHKKSCTKTPPILIMN 100 

OSEEEGSDAKRRRSEETRVCEKCCAEFFDEAEFLEHERNCTKSOQVVIMK 78 

DSEGPVPSEDFSRAALSHQLGSPSNK--DSLQENGSSSGDLKKLGTDSIL 148 

DGDGSEVPPEFSQRSPGDVLSDPCDQSTNSYSKHGAESDEMMEG-----E 123 

':\" • : 1; • .: 1'':t: : •• 1: •• 1;.:: : 7: .:: To: • * . :: : 
YLKTEATQPSTPQDIS----YLPKGRVANTNVTLQALRGTKVAVNQRGAE 194 
FMLNQDNPSNHDQEVSGSPGYVASSKLQDSNVTLESMAATKVAVTQHSSN 173 
it: :1; 
APHAPHPAAQ-------GIPur?LEQILCLQQQQLQQIQLTEQIRVQVNMW 237 
SSSQRSPPPQPHQDTLLAIPHILEQLVSLQQQQLQQIQLTEQIRIQVAHV 223 
AAHALHSGV-AGADTLKALSSHVSQQVSVSQQVSAAVALLSOKASNPALS 286 
APPSLHAAVGAVHDPLKALGAHLS------QQLSAAAALIGKRTGSQSLS 267 
LDALRQAKLPHASVPSAASPLSSGLTSFTLKPDGTRVLPNFVSRLPSALL 336 
1EA1KQAKLPQS--ATIPTSLPGGLGSIPLKPD-LRGLPDLASRLP-A1L 313 
1::1>1;1;101;1i**:: .:.: .1; •• 1i1i '"Ii: .1i1i1l1i : 1;1>:: .1i1r1i1i 1;1>1; 
PQTPGSVLLQSPFS--AVTLDQSKKGKGKPQNLSASASVLDVKAKDEVVL 384 
PQSPGVIGLQSPFNNLATSHDPSKKAKTKGPVVSEPPKNVSVEHS----- 358 
T1i:~1i : 1;*1:1;1; 1i.::~ 1iW1i.~ ~ :10 ..• : .. ~: .. 
GKHKCRYCPKVFGTDSSLQIHLRSHTGERPYVCPICGHRFTTKGNLKVHL 434 
FKHKCKFCGKTFGNDSALQIHLRSHTGERP FKCUICGNRFTTKGNLKVHF 408 
gi1321727751gb1AAH53716.11 
giI123705627IrefINP_001074078. 
gl1321727751gb1AAH53716.11 
giI123705627IEefINP_001074078. 
gi1321727751gb1AAH53716.11 
gil 123705627 IrefINP_001074078. 
gi1321727751gb1AAH53716.11 
giI123705627IEefINP_001074078. 
gil 32172775 19b IAAH53716. 1 I 
giI123705627 IrefINP_001074078. 
QRH----PEVKANPQLLAEFQDKGAVSAASHYALPVPVPADESSLSVDAE 480 

QRHKEKYPHIKMNPHPVPEHLDNMPSNNGIPYGHSVPHEENGFSETKPVL 458 

1;.:'t *1>: :.1;. 10: • • • 1:'.: .'ti*: 1< : 
PVPVTGTPSLGLPQKLTSGPNSRDLMGGSLPNDHQPGPSPESEAGLP--- 527 

GVPTTGPPAGPHPPVLQAFKPSFDIPAAGDPYSQRPSSSGSDGASISSGH 508 

** . 111; • 10: * 1:: 1; 1:: .... 1; • : 1i •• 1; 1; .. : .. 
----LLGVGHIHNPPKAGG----FQGTGAP-ESGSETLKLQQLVENIDKA 568 
FGQDIAGSDQSKDSPDAHVGLHHINGNSLTGENGSGTAKLQOMVDCLEKR 558 
: ." : : • 1i. 1; 
TTDPNECLICHRVLSCQSSLKMHYRTHTGERPFQCKICGRAFSTKGNLKT 618 
TNDPNECVICHRVLSCQSSLKMHYRTHTGERPYKCKICGRAFSTKGNLKA 608 
*.~~~*~:~*W~1i~~T1i*~~~T1r1i~~~*~~W1i::*~**~~1i~~~~**1:'w: 
HLGVHRTNTTVKTQHSCPICQRKFTNADHLQQHIRMHHGGQIPNTPLPE- 667 
HYGVHRANTP LKM:QHS CP I CHKKFTNAVVL QQHlronmGGQIPNTPLPEU 658 
~ *~**:~*.:~ 1i*~1i*1;~:1i1r7*W1i :**1;*1iW1i1i**~~~W1r*1r1;1r1i 
Fig 2.4: Sequence alignment of zebrafish Sa1l4 gene against mouse Sa1l4 
(http://'''Ww.ncbi.nlm.nih.govO. Antigenic peptide was raised from within 
residues 350 to 450 of mouse Sa1l4. 
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2.3.2 IMMUNO CYTOCHEMISTRY (ICC) 
To determine the localization of proteins in cultured cell, tissues, oocytes and 
embryos, ICC employs antibodies raised against specific proteins of interest. For 
the successful detection of antigen samples need to be fixed, which helps in 
preserving the antigenicity of proteins. The sample also needs to be permeabilized 
if protein of interest is not on the cell surface. Often antibodies can bind non­
specifically to proteins other than they are raised against. For this purpose samples 
are pre-incubated in a blocking solution which contains BSA that bind to these 
non-specific sites. Consequently the primary antibodies bind to the higher affinity 
specific sites than the blocking proteins. In order to remove excess antibody that 
has not bound to the target protein samples need to be washed after primary 
antibody incubation. Cells are than incubated with secondary antibody that is 
raised against primary antibody and contains a fluorescent tag. After further 
washes to remove excess secondary antibody, samples are ready to be visualized 
for the localization of target protein within a cell with fluorescent microscopy. 
Confocal Microscope is a high powered imaging device that image either by 
reflecting light off the specimen or stimulating fluorescence from dyes applied to 
the specimen. It allows visualization of fluorescence along one plane, providing 
detailed analysis of protein localization in cells. As compared to conventional 
microscope it creates sharper, more detailed 2D images and allows collection of 
data in three dimensions (Semwogerere and Weeks, 2005) 
2.3.2.1 PROCEDURE 
2.3.2.1.1EMBRYO COLLECTION 
Embryos were collected at different developmental stages e.g. early blastula stage, 
high stage, oblong stage, dome stage and 50% epiboly. 
After collection, embryos were placed in pronase solution (0.5 mg/ml) for 10 min 
or until chorions break apart. Dechorionated embryos were placed in fresh embryo 
medium. Cells were dissociated by gentle pipetting. Dissociated cells were placed 
on gelatin coated coverslips and left for attachment. 
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2.3.2.1.2 IMMUNOCYTOCHEMISTRY 
The chemicals used in immunocytochemical analysis are shown in Table 2.2. 
Coverslips were fixed in 4% formaldeyhde in PBS for 20 minutes, washed three 
times with PBS and then permeabilized in 0.5% triton X-IOO in PBS for 10 
minutes at room temperature. Cover slips were then washed in 0.1 % triton X 100 
in PB S for three times and blocked in 2% BSA in 0.1 % triton X IOO at 40 C 
overnight. 
Blocked coverslips were incubated with primary antibody, rabbit polyclonal to 
Oct 4 and rabbit polyclonal to sa1l4 (Abeam, UK) overnight at 4°C. After three 
washes with PBS, coverslips were incubated with secondary antibody Alexa flour 
594 and 488 anti- rabbit IgG (Invitrogen, UK) for 2 hours at room temperature. 
Table 2.3 shows the detail of antibodies and their concentrations. As negative 
controls, cells were incubated only with secondary antibody. After washing three 
times with PBS, cover slips were mounted on slides in vecta shield containing 4', 
6-diamidino-2-phenylindole (DAPI). 
!' Table 2.2 List of chemicals prepared for immunocytochemical analysis 
I• CHEMICALS 
I 
4% formaldehyde in PBS 
0.5% triton X-IOO in PBS 
• 0.1% triton X-IOO in PBS I 
I 
2% BSA with 0.1 % triton X-IOO 
Phosphate buffer saline (PBS) 
•
• 
USE 

Fixing solution. 

Permeabilizing solution. 

Washing solution. 

Blocking solution. 

Washing solution. 
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Table 2.3 Antibody details and concentration 
Protein 	 Primary AB Primary AB Secondary AB Secondary AB 
concentration concentration 
Oct4 	 Rabbit IgG anti- 5llg/ml Alexa Flour ® 51lg/m1 
Oct4 594 anti-
rabbit IgG (Abeam) 
Sa1l4 	 Rabbit IgG anti- S Ilg/ml Alexa Flour ® 5llg/ml 
Sa1l4 488 anti-
rabbit IgG (Abc am) 
All the experiments were run in triplicates. 
2.3.2.1.3 CONFOCAL MICROSCOPY 
Immunostained samples were examined and imaged upside down using the Leica 
TCS SP5 confocal microscope and scanner and fluorescence data was collected 
using Leica Confocal software (Leica). DAPI fluorescence was excited at 405nm, 
FITC (Fluorescein isothiocyanate) was excited at 488nm and TRITe (Tetramethyl 
Rhodamine Iso-Thiocyanate) was excited at 594nm. Each image was produced 
from the average fluorescence data obtained from 4 scans, thereby reducing 
background fluorescence. 
2.3.2.1.4 QUANTIFICATION OF PROTEIN EXPRESSION 
The protein expression in the immunostained cells was assessed on the basis of 
the size of protein clumps, distances between the clumps and their distribution in 
the cell or nucleus. Three different areas of the coverslip were analyzed per 
replicate. All the measurements were carried out using Image J software. 
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2.4 CULTURING OF ZEBBRAFISH BLASTOMERES 

-

2.4.1 MEDIA PREPARATION 
Embryonic cells were derived in LDF basal nutrient medium. LDF media was 
prepared by combining Leibowitz's L-15, Dulbecco's Modified Eagle's Medium 
and Ham's F12 in a ratio of 50:35:15 supplementing with sodium bicarbonate 
(0.180g/l) and sodium selenite (10-8 M). The following culture media (Table 2.4) 
were available from sigma Aldrich: Leibowitz's LIS, Ham's F 12, and 
Dulbecco's modified eagle's (DMEM). One liter of each medium was prepared by 
dissolving the powder in ddH20. HEPES buffer was added at a final 
concentration of 15mM pH 7.2. The following antibiotics were used at penicillin 
and streptomycin sulfate at a final concentration of 30ug/ml and 50ug/ml 
respectively. The medium was filter sterilized before use. 
Table 2.4 Chemical composition of culture medium 
INGREDIENTS CONCENTRATION SOURCE 
Leibowitz's L-15 50% SIGMA- ALDRICH 
Dulbecco's Modified 35% SIGMA- ALDRICH 
Eagle's medium (DMEM) 
•Ham's F 12 15% SIGMA- ALDRICH 
Sodium bicarbonate O.l8g/l SIGMA- ALDRICH 
HEPES buffer 15mM SIGMA- ALDRICH 
Sodium selenite 1O-8 M SIGMA- ALDRICH 
Penicillin 30)lg/ml SIGMA- ALDRICH 
Streptomycin 50)lglml SIGMA- ALDRICH 
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• 
• 
• 
• 
• 
2.4.2 GROWTHFACTORS 

The information on growth factors in the medium used in the experiments is 
provided in Table 2.5. 
Table 2.5 List of growth factors supplemented in culture medium 
Ingredients 
Fetal Bovine Serum 
Epidermal Growth Factor 
I 
Human Insulin 
Concentration Source 
5% 
SOng/ml 
10/-1g/ml 
SIGMA-ALDRICH 

SIGMA-ALDRICH 

SIGMA-ALDRICH 

Human insulin the stock solution was prepared at 1 mg/ml in 20mM Hcl (final 
conc. lOng/ml). 
Epidermal growth factor the stock solution was prepared inlmg/ml in LDF 
medium (final conc. SOng/ml). 
Basic Fibroblast growth factor the stock solution was prepared at 2S)lg/ml in 
filtered 20mM Tris (PH 7). 
•
1 
2.4.3 GROWTH EVALUATION •I. 
II 
Cell growth was evaluated on the basis of two parameters i.e. measurement of 
diameter of embryonic cell colonies and colony no. The calculations were done 
I for three different areas of the well per replicate. The diameter was measured 
I 
using Image J software. 
2.5 STATISTICAL ANALYSIS 
•
• 	 Results were expressed as mean ± SD. Student t test was used to evaluate the 
statistical significant difference between the groups (P< 0.05), means, standard 
deviation and t test were calculated using Excel version 2010 for windows. 
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2.6 IMAGE ANALYSIS 
All image analysis on cell cultures and immunostained samples was done by 
Image J software (http://rsbweb.nih.gov/ijl). 
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3 RESUL TS AND DISCUSSIONS 
3.1 Identify molecular markers for pluripotency ES cells in zebrafish 
The establishment of mouse embryonic stem cell culture has enabled the 
production of knock out mutants in this specie which is a valuable approach to 
study gene function (VanDer Weyden et ai, 2002). There has been a continuous 
effort for establishing of ES cell lines in other species as well. Although the 
methods for zebrafish ES cell like derivation has been described in literature, 
efficient production of gene knock outs has not been achieved in this specie 
(Robles et aI, 2011). Targeted inhibition of gene expression in zebrafish using 
antisense phosphoramidite morpholino oligomers (MOs) has been studied 
(Nasevicius and Ekker, 2000) and both Doyon et a1 (2008) and Meng et al (2008) 
demonstrated the successful use of zinc finger nucleases for targeted gene 
inactivation in zebrafish. However cell mediated gene transfer in ZF cell cultures 
is still not attained. There are reports demonstrating the germ line competency of 
zebrafish cell cultures (Fan et aI, 2004) and homologous recombination has been 
carried out in these cultures (Fan et aI, 2006). Regardless of these advances, only 
blastula derived cell lines have been established instead of ESC lines (Xing et aI, 
2008). One of the major hurdles is the lack of knowledge of piuri potency markers 
in this specie. Studies were carried out by Robles et al (2011) on expression of 
different pluripotency genes in zebrafish embryonic stages and cultures. 
The aim of this study was to investigate the expression of two pluripotency 
markers Oct4 and Sa1l4 in different zebrafish embryonic stages e.g. from early 
blastula to high, oblong, dome and 50% epiboly stage. It is reported (Kimmel and 
Warga, 1986; Ho, 1992; Ho and Kimmel, 1993; Strehlow and Gilbert, 1993) that 
pluripotent cells can be successfully isolated from blastula stages in zebrafish. We 
aimed to identify most suitable blastula stage in zebrafish for the isolation of 
pluripotent cells for successful establishment of embryonic stem cell cultures. 
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3.1.1 OCT4 
Oct4 is an important and well recognized pluripotency marker for human and 
mouse embryonic stem cells (Nichols et aI, 1998; Niwa et aI, 2000). In the present 
study, investigations were carried out on Oct4 protein expression in zebrafish at 
different embryo developmental stages. 
In order to see the localization and abundance of Oct4 protein in different embryo 
developmental stages; cells from all embryo stages to be analysed were isolated, 
fixed, permeabilized and blocked as described in section 2.3.2.1.2. The blocked 
cells were then incubated in primary antibodies overnight and with secondary 
antibody for 2 hours with the concentrations stated in Table 2.3. Confocal 
microscopy was carried out as described in section 2.3.2.1.3. 
The immunostained cells revealed different staining patterns for protein 
expression. The protein expression was categorized on the basis of the size of the 
protein clump, its arrangement in the nucleus and intensity of expression (the area 
of nucleus covered with protein) and cytoplasmic staining. There were broadly 
four categories (Fig 3.1) observed on the basis of criterion mentioned above and 
observed the type of pattern present at each stage. 
In early blastula stages there was cytoplasmic staining evident in addition to 
nuclear localization. Cytoplasmic staining was also reported in murine pre­
implantation embryos at around 8 to 16-cell stage and then protein started to 
localize in nuclei (Palmieri et aI, 1994; Hubner et aI, 2003). The protein speck size 
was roughly around O.l!lm and was sparsely present throughout the nucleus. The 
cytoplasmic staining indicates that Oct4 protein is being synthesized at this stage 
and is also being translocated to the nucleus. The next category showed the peak 
expression of Oct4 protein. Big sizes of protein clumps around 2!lm were 
compactly present throughout the nucleus. The protein expressed approximately 
the whole area of nucleus. There was no Oct4 cytoplasmic staining found and it 
can be assumed that after early blastula stage the Oct4 gene is switched off and all 
the protein has localized in nucleus to perform its role to maintain pluripotency. 
This staining pattern was assumed to be the highest protein expression and can be 
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• 
suggested that pluripotent cells should show protein expression similar to this 
category. In our analysed stages this expression pattern was observed in only high 
stage blastomeres. The third category showed low levels of Oct4 protein as 
compared to category 2. The protein clump size was reduced to app. 1 Ilm and the 
area of nucleus covered by the protein was also reduced. However the clumps 
were present interconnected throughout the nucleus. In fourth category the protein 
speck size was further reduced to around 0.05 )lm and protein specks were 
scattered though out the nucleus and were apart from each other. In the oblong, 
dome and 50% epiboly blastomeres, two types of staining categories i.e. Category 
3 and 4 were observed. Different ratio of cells from the stages was present in both 
categories. The results indicated that blastomeres are most pluripotent at high 
stage and started to lose pluripotency afterwards as indicated by the decrease in 
protein expression. 
I* 
I 
I•
•
••I
•
• 
I, 
II 
•
I 
*•II 
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Fig 3.1: Different Staining patterns obsel'ved for Oct4 protein localization. Cytoplasmic and nucleal' localization of 
Oct4 at early blastula stage. Oct4 protein started to localize in nucleus after early blastula stage with a dense 
expression at High stage. At later stages Oblong, Dome and 50% epiboly the protein expl'ession has decreased. 
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Studies carried out in human and murine embryonic stem cells demonstrated the 
crucial role played by Sa1l4 in the maintenance of pluripotency. Sa1l4 plays its 
role through transcriptionally modulation of Oct4 and Nanog in maintaining 
undifferentiated phenotype of ESCs and governing the fate of rCM (Yang et aI, 
2008). Down-regulation of Sa1l4 resulted in subsequent low levels of Oct4, Sox2, 
Klf4 and c-Myc; these genes are involved in reprogramming of somatic cells to 
IPSCs. So Sal14 can be proposed as a key regulator in reprogramming process 
(Yang et aI, 2008). There is limited infonnation in the literature on the role of 
Sa1l4 in zebrafish embryos and cultured embryonic cells. Robles et al (2011) 
reported the expression of Sa1l4 gene in zebrafish oblong stage embryos in 
comparison with adult somatic cells. 
Sa1l4 protein expression at different embryo development stages were investigated 
using immunostaining. As observed with Oct4 expression, Sal14 protein also 
showed various expression patterns in the cells. These patterns were classified as 
sho\\-TI in Fig 3.2. The different developmental stages were than classified into the 
categories. Staining patterns were broadly classified into 4 categories on the basis 
of size of the protein, their spatial location in nucleus, and cytoplasmic• 
localization. 
The protein staining patterns were somewhat similar to Oct4 expression and it 
confinns that both genes are interrelated. Category 1 consists of expression of
•.. Sa1l4 protein localization to cytoplasm and protein speck size was around 0.1 ~lm 
I
•• 
present interconnected throughout the nucleus. Early blastula stage blastomeres 
showed this type of staining pattern. Similar to Oct4 expression at early blastula 
stage, there was cytoplasmic expression of Sa1l4 evident which indicates that 
Sa1l4 protein is being synthesized at this stage. However as we moved to later 
stages no cytoplasmic expression of Sall4 protein was found. It can be supposed
-
• that Sa1l4 gene has turned off. Category 2 comprised of staining pattern exhibiting
I 
protein clumps greater than 1 !lm which are compactly present throughout the*•I nucleus. High levels of Sall4 protein were expressed as evident from the fully 
immunostained nucleus. The third category consisted of protein clumps which 
have reduced in size to less than l!-lm and present throughout the nucleus. 
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-However the Sa1l4 levels are lower as compared to category 2. The fourth 
category constitute of protein specks around 0.05)lm present throughout the 
nucleus with l)lm apart. High stage blastomeres were placed in Category 2 and 
100% of the blastomeres showed this protein expression and it is assumed to be 
the highly expressed Sall4 protein category. All of the oblong stage blastomeres 
showed staining pattern of Category 3 in which protein expression levels are 
reduced as compared to Category 2. As we move on to the next blastula stage i.e. 
dome stage, it showed two type of staining patterns. A greater proportion of the 
cells showed staining pattern similar to Category 3 and a lesser no. showed of 
Category 4. At 50% epiboly all of the cells showed protein expression pattern of 
Category 4. This indicates that maximum protein expression is at high stage and 
consequently it can be proposed that cells are most pluripotent at this stage. In 
later stages the protein expression is decreased evident from small protein size and 
it can be proposed that cells have started to lose pluripotent nature. 
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Fig 3.2: Different staining patterns observed for Sa1l4 protein localization. Cytoplasmic and nuclear localization of Sall4 

protein at early blastula stage. Sall4 protein star·ted to localize in nucleus after early blastula stage with a dense expression at 

High stage. At later stages Oblong, Dome and 50% epiboly the protein expression has decreased. 
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throughout nucleus. nucleus. nucleus with 1 urn apart. interconnected 
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3.2 EMBRYONIC CELLS DERIVATION FROM ZEBRAFISH HIGH 
STAGE EMBRYOS 
Studies carried out on the pluripotency markers Oct4 and Sa1l4 at different 
zebrafi sh embryo stages demonstrated highest expression of pluripotency genes at 
high stage (Fig 3.3). At High stage cells are considered to be pluripotent as it is 
widely accepted that cell type determination does not occur before the beginning 
of gastrulation. Lin et al (1992) demonstrated that a small no of ceJ Is from blastula 
stage when transplanted into other blastula stage embryos participated in 
formation of many cell types including a germ line in the recipient. So, the 
blastomeres were isolated from this stage and derived in LDF medium 
supplemented with epidermal growth factor, bovine insulin and FBS (5%), on 
gelatine coated wells. 
There have been reported methods for the derivation of zebrafish ES cells (Fan et 
aI, 2004; Xing et aI, 2008). However the medium composition is quite complex 
and consists of various supplements e.g. zebrafish embryo extract, trout plasma 
which are not available at ease in every laboratory. We aimed to simplify the 
protocol for culturing of zebrafi sh embryonic cells. 
Fig 3.3: Zebrafish embryo at high stage (Kimmel ct ai, 1995) 
Although methods for ES ceU derivation from zebrafish embryo have been 
described in the literature these cultures are not suitable for cell med iated gene 
transfer in this specie. The most suitable stage identified for stem cell derivation is 
oblong stage but the cultures obtained are blastula derived cell lines instead of ES 
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cell lines (Xing et ai, 2008). We have attempted to isolate pluripotent cells from 
zebrafish embryos at high stage based on our immunocytochemistry analysis of 
the expression of pluripotency genes. 
3.2.1 EFFECT OF FOETAL BOVINE SERUM (FBS) ON EMBRYONIC 
CELL CULTURE 
Blastomeres were isolated from high stage zebrafish embryos and cultured on 
gelati ne coated 24 well plate. 10 embryos per condition were used. Zebrafish 
embryonic cells were cultured in LDF medium supplemented with epidermal 
growth factor (SOng/ml), bovine insulin (lO).lg/ml) and foetal Bovine serum (S%). 
The cell growth was evaluated by measuring the diameter of embryonic cell 
colonies and the no. of colonies/ mm2 present as described in section 2.4.3. The 
cell growth appeared to be slow as there was not a considerable No. of colonies 
and the increase in their diameters over time. So another FBS concentration (l 0%) 
was tested. 
Both parameters i.e. embryonic cell colony diameter and no of colonies were 
determined in boLh FBS concentrations. Fig 3.4 and Fig 3.S show the comparison 
of S% FBS and 10% FBS conditioned medium using either of the parameters. 
There were signifi cant differences (p<O.OS) between 5% and 10% FBS 
supplemented LDF medium when either of the parameters was used. 
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Fig 3.4: Effect of FBS on diameter of embryonic cell colonies in 5% and 10% 
FBS supplemented LDF medium. Error bars represent standard deviation 
from mean. Different letters indicate significant difference (p<O.OS, n=9) 
between the two conditions on same day. 
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Fig 3.5: Effect of FBS on embryonic cell colony no. in 5% and 10% FBS 
supplemented LDF medium. Standard bars indicate standard deviation from 
the mean. Different letters indicate significant difference between different 
culture conditions on the same day (p<O.05, 0=9). 
These results indicated that 10% FBS supported better growth of embryonic cell 
colonies. Fig 3.6 shows the appearance of embryonic cell colonies in 10% FBS 
conditioned mediwn. Cultured embryo cells showed aggregate formation on Day 
1 (Fig 3.4 A). Appearance of embryonic cell colony on Day 3 showed an increase 
in aggregate size. Some colonies exhibited neurite formation (projections 
extending from the periphery of aggregates (Fig 3.4 B). Fig 3.4 D displays the 
appearance of melanocyte (red arrow) in embryonic cell colony and 
diffe rentiation of few embryonic stem cells in embryo fibroblasts (black arrow). 
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A 
C 
Fig 3.6: 
Culture (Day 1) embryo ceU aggregates (B) Culture (Day3) without any 
neurite formation (C) Culture (Day 6) embryonic cell colony with 
projections (neurite) extending out of cluster (D) culture (Day 6) the 
differentiation of few embryonic cells into embryo fibroblast cells (black 
arrow) and presence of mealnocytes (red arrow). 
3.2.2 EFFECT OF FIBROBLAST GROWTH FACTOR (bFGF) ON CELL 
CULTURE 
In our culture system, blastomeres isolated from high stage were cultured in LDF 
medium supplemented with epidermal growth Factor and Bovine insulin. The 
isolated cell s were of spheroid shape when cultured. The cells approached each 
other and tend to form cel l colonies. These colonies were circular in morphology 
and tend to grow as evidenced from their increase in diameter. However 
approximately on Day 3 there was appearance of outgrowths (long extension) 
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Phase contrast photomicrograph of embryonic cell colony. (A) 
shown in Fig 3.7 B, which was assumed to be neurites (Sun et aI , 1995). emerging 
from the cell aggregates. The neurite formation was assumed to be indication of 
neuronal differentiation in the cell colonies. 
The addition of bFGF to the culture medium resulted in inhibition of neurite 
fo rmation shown in Fig 3.7 A till day 6 of culturing as compared to non-bFG 
supplemented medium where neurite formation started on approximately day3 of 
culturing. 
A 

.~, 
J . 
:, 
Fig 3.7: Phase contrast photomicrographs of zebrafish embryonic cell colony 
at Day 6. A: Embryonic cell colonies in bFGF supplemented medium. There 
was no evident growth of neurite (projections) from cell clusters. B: 
Embryonic cell colony in non-bFG F supplemented medium with neurite 
(arrow), indicating neural cell differentiation has occurred, extending out of 
the aggregates (scale bar 250 J.lm). 
It has been reported prev iously that addition of bFGF to the zebrafish embryonic 
cultures resulted in stimulation of proliferation and melanogenesis inhibition in 
culture system (Bradford et ill, 1994). Singh et al (2001) demonstrated that 
add ition of bFGF to zebrafish early embryo cultures resulted in the suppression of 
neural-specific markers. Likewise there are evidence that bFGF in concert with 
other growth factors play role in the maintenance of undifferentiated hESC in 
absence of feeder layers (Wang et aI, 2005 ; Xu et aI , 2005; Xu et aI , 2005). We 
report here that add ition of bFGF in our cultures resulted in total inhibition or 
neurites fo rmation in cell colonies. 
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Fig 3.8: Diameter of Embryonic colonies cultured in bFGF supplemented 
medium. Different letter indicates significant difference (p<O.OS, n=9). 
Fig 3.8 shows the growth of zebrafish embryonic cell colonies in bFGF 
supplemented medium. There was increase in diameter of embryonic cell colonies 
over the period of six days. Therefore, bFGF had no effect in inhibiting the 
growth of colonies. 
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Compari son of neurite forming colonies in culture medium without bFGF and 
with bFGF is shown in Fig 3.9 till day 6 of cell cultUling. There was significant 
difference (p<O.05) found in the No. of neurite forming colonies in both 
conditions which shows that bFGF played an important role in inhibiting neuronal 
differentiation in embryonic cell colonies. 
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Fig 3,9: Comparison of neurite forming colonies in bFGF supplemented and 
non-bFGF supplemented medium till Day 6 of cell culturing. Different letters 
indicate significant difference (p<O.OS, n=9). 
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Comparison of diameter and No. of embryonic cell colonies cultured in bFGF 
supplemented medium and non-bFGF supplemented medium is shown in Fig 3.10 
and 3.1 1. There were no significant differences (p<O.05) found for both 
parameters i.e. embryonic cell colony diameter and number in both culture 
conditions. So bFGF neither enhanced nor inhibited the growth of embryonic cell 
coloni es . 
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Fig 3.10: Comparison of embryonic cell colony diameter over the period of 6 
days in bFGF supplemented and non-supplemented medium. Standard bars 
represent standard deviation. 
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3.3 APPLICATION OF PLURIPOTENCY MARKERS ON CULTURED 
CELLS 
The immunocytochemistry analysis of Oct4 and Sa1l4 protein in different 
zebrafi sh embryo stages revealed some promising results that these genes can be 
used as markers for the identification of pluripotent nature of zebrafish embryonic 
stem celL. 
The aim of this experiment was to test the application of these markers on the 
embryonic cell cultures at various culture periods. The expression of Oct4 and 
Sall4 was analysed in emblyonic cell colonies cultured in non-bfGf supplemented 
medium. In Fig 3.12 A the embryonic cell colony is stained with Oct4 on Day 6. 
The protei n expression pattern was similar to Category 3 in which protein speck 
size has reduced to less than 111m and though it is present throughout the nucleus 
but the expression is not very dense as compared to Category 2 expression which 
is assumed to be shown by the pluripotent cells. So it can be proposed that the cell 
colony has already started to lose pluripotency and it is also evident from the 
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culturing results that usually around Day 3 embryonic cell colonies started to 
differentiate. The other two images Fig 3.12 A & B are the immunostained 
zebrafish embryo fibroblasts. Their expression pattern was found to be similar to 
Category 4 which was exhibited by some cells at 50% epiboly stage and at this 
stage it is also considered that cell fate determination has occurred (Kimmel and 
Warga, 1986; Ho, 1992; Ho and Kimmel, 1993; Strehlow and Gilbert, 1993). The 
protein speck size was the minimum in Category 4 and can be considered as the 
expression shown by differentiated cells. So, the fibroblasts exhibited the 
expression pattern demonstrating that they have lost pluripotency. This validates 
that Oct4 marker is well capable of identifying the pluripotent status of cultured 
embryonic cells. 
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Fig 3.12: Immunocytochemistry analysis for Oct4 protein in embloyonic cell 
cuJtures. (Merged image; DAPI, blue; Oct4 red) (A) Embryonic cell colony 
on Day 6. (8) Embryo fibroblasts (elliptical nuclei), on Day3 and Day4 in 
10% FBS conditioned medium. 
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In Fig 3.13 the embryonic cell cultures are stained with Sa1l4 antibody. The two 
embryonic cell colonies stained on same Day 11 of culturing. The embryonic cell 
colony in Fig 3.13 A shows expression pattern similar to Category 3 in which 
protein size is reduced to <l!-lm and protein is present interconnected throughout 
the nucleus. The embryonic cell colony in Fig 3.13 B depicts the Sa1l4 protein 
expression of Category 4 in which the expression was red.uced as compared to 
Category 2 which showed highest nuclear expression. The protein speck was 
reduced to less than 0.05 !-lm and were scattered in whole nucleus. The expression 
patterns depicted by embryonic cell colonies demonstrated that these colonies 
have already started to differentiate. This is in line with our cell culture results 
that the cell colonies showed signs of differentiation i.e. neurite, onwards Day 3 of 
culture in non-bFGF supplemented medium. 
The third image Fig 3.13 C is of embryo fibroblast which showed low levels of 
Sa1l4 protein and also exhibited cytoplasmic staining. These results indicated that 
the Sall4 marker worked well for the cultured embryonic cells and is able to help 
in identification of differentiated or undifferentiated phenotype of embryonic cell . 
colonies. 
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Fig 3.13: Immunocytochemistry analysis for the presence of Sall4 protein in 
embryonic ceU cultures on Day 11 (Merged image; DAPI, blue; Sa1l4, green). 
(A & B) SaJl4 protein expression pattern in embryonic cell colonies. (B) 
Protein expression pattern is similar to category 3. (C) Protein expression 
pattern is similar to category 4. (C) Diminished expression of SaIl 4 protein in 
nuclei of embryo fibroblast. 
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4 CONCLUSIONS 
4.1 SUMMARY OF RESULTS 
Studies were carried out on the protein expression of two pluripotency genes Oct4 
and Sa1l4. The protein expression employing immunocytochemistry was carried 
out in different zebrafish embryo developmental stages. Results demonstrated that 
there were different staining patterns for protein localization in cells. Different 
developmental stages were then placed in these groupings. The staining patterns 
were analysed on the basis of protein size, its localization pattern in cytoplasm or 
nucleus. Based on these analyses a peak expression of both Oct4 and Sa1l4 was 
observed in blastomeres isolated from high stage zebrafish embryos. The protein 
clump size of both Oct4 and Sa1l4 was maximum (>2~m) at this stage. Likewise 
the protein clumps were present compactly throughout the nucleus and almost 
whole area of the nucleus was stained with the protein. It can be assumed that 
cells are most pluripotent at this stage as compared to other blastula stages i.e. 
128-cell stage, oblong stage, dome stage and 50% epiboly. The protein expression 
patterns at these stages demonstrated either the protein has started expressing or 
has started to degrade. At 128-cell stage there was cytoplasmic protein 
localization and protein speck size of both Oct4 and Sall4 was around 0.1 J.lm 
which can be maternally expressed protein. Zebrafish embryos undergo mid 
blastula transition (MBT) at 512-cell stage (Kimmel et al, 1995). Consequently a 
peak protein expression was observed at high stage which follows 512-cell stage. 
The later zebrafish embryo stages i.e. oblong stage, dome stage and 50% epiboly 
showed a reduced protein expression evident from decrease in protein size and 
sparse localization in nucleus. These findings suggest that Oct4 and Sa1l4 can be 
suitable pluripotency markers in zebrafish specie. 
The outcomes of the experiments for the expression of pluripotency genes led to 
the identification of a suitable blastula stage i.e. high stage for the isolation of 
pluripotent cells. Embryonic cell isolated from high stage were culture in LDF 
medium. Cell growth was evaluated at two FBS concentrations i.e. 5% and 10%. 
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Embryonic cell colony diameter and colony no. indicated better growth when 10% 
FBS is used. Experiments were then carried out on the effect of bFGF on 
differentiation inhibition in embryonic cell colonies. There was significant 
difference in neurite fonning colonies in bFGF supplemented and non-bFGF I 
I supplemented medium. Cell growth was evaluated on the basis of embryonic cell 
colony diameter and colony no. There was no significant effect of bFGF found on 
growth of embryonic cell colonies. 
The developed pluripotency markers were then analysed on cultured embryonic 
i 
cells to check their suitability for identification of pluripotent nature of culturedI 
I embryonic cell. The immunostained embryonic cell colonies exhibited different 
I 
• 
protein expression patterns which can be placed in the categories identified for the 
zebrafish blastomeres. The Oct4 and Sa114 protein expression pattern of cultured 
embryonic cell colonies identified that these colonies had already start to 
differentiate. This is in line with our cell culture results which indicated that 
I embryonic cell colonies started exhibiting signs of differentiation i.e. neurite 
I formation, fibroblasts appearance from Day 3 onwards of culturing.
I 
4.2 CONCLUSION 
The results from the present study showed that the maximum expression of 
pluripotency genes Oct4 and Sall4 was f01md in blastomeres isolated from high 
stage zebrafish embryos. Oct4 and Sa1l4 are well studied pluripotency markers in 
human and mouse, but there is not much reported work on the protein expression 
of these markers in zebrafish. It is for the first time the expression of these 
proteins at different developmental stages of zebrafish embryos is reported. The 
results showed that the blastomeres at high stage have the highest pluripotent 
nature and zebrafish embryonic cell cultures should be derived from this embryo 
developmental stage. 
Secondly bFGF was found to inhibit neurite formation in our cultured cells, 
though it has been previously reported that bFGF inhibited melanogenesis and 
stimulated proliferation in cultured zebrafish embryonic cells (Bradford et aI, 
1994). Likewise Singh et al (2001) reported suppression of neural markers in 
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bFGF supplemented zebrafish embryonic cell cultures. The morphological effect 
of bFGF in inhibiting neurite formation is reported here for the first time. 
The applicability of developed pluripotency markers Oct4 and Sa1l4 was also 
tested on cultured embryonic cells. Although the staining patterns showed that 
embryonic cell colonies started to differentiate in our cultures from Day3 onwards, 
it confirmed the pluripotency markers worked well in identification of the 
pluripotent nature of embryonic cell colonies. Furthermore the staining patterns of 
fibroblast which are terminally differentiated cells is very similar to the staining 
patterns of blastomeres at 50% epiboly stage when cell fate determination has 
occurred and cells have lost pluripotency. Overall these markers are well suited 
for pluripotency determination in zebrafish and the findings from the present 
study will have important application in future zebrafish ES cell culture 
development. 
4.3 FUTURE WORK 
More detailed studies should be carried out on the analysis of other pluripotency 
genes reported in mouse and human species which would help in identifying more 
suitable culture conditions for zebrafish embryonic stem cells. To further confirm 
the expression of Oct4 and Sa1l4 at different zebrafish blastula stages analysed, 
relative gene expression studies should be carried out employing real time peR. 
In these studies the application of the pluripotency markers was evaluated on 
cultures in non-bFGF supplemented medium where embryonic cell colonies had 
already started to differentiate. The applicability of the markers should also be 
tested on the cultures in bFGF supplemented medium. In the case that colonies are 
pluripotent, pluripotent cells can be reliably isolated from zebrafish embryo at 
high stage. More studies should also be carried out on identifying more suitable 
culture conditions for derivation of embryonic cells from high stage. 
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